Insider Trading & Ownership - Sofinnova Partners SAS

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Sofinnova Partners SAS
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-08-15
Purchase
2022-08-17
4:19 pm
CinCor Pharma Inc.CINCSofinnova Partners SAS
Sofinnova Capital IX
10% Owner
133,333$30$3,999,9904,220,979
(Indirect)
View
2022-01-11
Purchase
2022-01-13
4:36 pm
CinCor Pharma Inc.CINCSofinnova Partners SAS
Sofinnova Capital IX
10% Owner
220,000$16$3,520,0004,087,646
(Indirect)
View
2021-04-21
Sale
2021-04-23
4:30 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
328,620$11.6$3,812,3863,177,574
(Direct)
View
2021-03-29
Sale
2021-03-31
4:06 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
36,829$13.67$503,5703,506,194
(Direct)
View
2021-03-26
Sale
2021-03-31
06:01 am
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
35,171$13.69$481,6423,543,023
(Direct)
View
2021-03-25
Sale
2021-03-29
4:01 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
28,546$13.12$374,5693,578,194
(Direct)
View
2021-03-24
Sale
2021-03-26
7:12 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
52,690$13.7$721,6163,606,740
(Direct)
View
2021-03-23
Sale
2021-03-25
6:13 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
40,000$13.91$556,4763,659,430
(Direct)
View
2021-03-22
Sale
2021-03-24
6:16 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
40,534$14.54$589,2633,699,430
(Direct)
View
2021-03-19
Sale
2021-03-23
4:31 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
166,230$14.6$2,427,7393,739,964
(Direct)
View
2020-10-02
Sale
2020-10-06
4:01 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
300$10$3,0003,906,194
(Direct)
View
2020-09-15
Sale
2020-09-17
4:02 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
41,597$12.61$524,4773,906,494
(Direct)
View
2020-06-29
Sale(A)
2020-07-24
5:07 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
3,280$11.78$38,6283,960,574
(Direct)
View
2020-06-29
Sale
2020-07-22
4:03 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
3,280$11.78$38,6283,960,574
(Direct)
View
2020-07-20
Sale
2020-07-22
4:03 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
12,483$11.94$149,1023,948,091
(Direct)
View
2020-06-29
Sale
2020-07-01
4:16 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
3,280$11.78$38,6283,960,574
(Direct)
View
2019-04-23
Purchase
2019-04-25
4:15 pm
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
357,142$14$4,999,9883,963,854
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-11
Conversion
2022-01-13
4:36 pm
N/A
N/A
CinCor Pharma Inc.CINCSofinnova Partners SAS
Sofinnova Capital IX
10% Owner
17,017,645$04,087,646
(Indirect)
View

Ownership
2022-01-06
8:56 pm
N/A
N/A
CinCor Pharma Inc.CINCSofinnova Partners SAS
Sofinnova Capital IX
10% Owner
0$03,867,646
(Indirect)
View
2019-04-23
Conversion
2019-04-25
4:15 pm
N/A
N/A
HOOKIPA Pharma Inc.HOOKSOFINNOVA CAPITAL VI FCPR
Sofinnova Partners SAS
10% Owner
3,524,256$03,963,854
(Direct)
View
(A) Indicate amendment filing.